MLXIPL and metabolic dysfunction-associated steatotic liver disease: Clarification of the role of ChREBP in lipid metabolism will be useful for therapeutic strategies in the treatment of non-alcoholic fatty liver disease (NAFLD) and hyperlipidemia.